Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis
Journal of Hepatology · 2026-02 · 84 (2) · 275-283
DOI: 10.1016/j.jhep.2025.09.024 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Hepatology, 2026-02. Verfasst von Yu Jun Wong und 59 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Liver Unit, University of Alberta, Edmonton, Canada; Department of Gastroenterology & Hepatology, Changi General Hos…. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Liver, Liver Cirrhosis, Biliary, Liver Failure. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND & AIMS: Both liver stiffness measurement (LSM) and biochemical response have prognostic significance in patients with primary biliary cholangitis (PBC). However, the frequency and clinical relevance of discordant biochemical and LSM changes remain unclear. We aim to determine the performance of the most recent or current LSM (LSMc) in predicting first hepatic decompensation (HD) in the setting of discordant biochemical and LSM responses. METHODS: In this international, multicenter study, we included patients with at least two reliable LSM performed at least 6 months apart. Patients with prior HD, liver transplantation or hepatocellular carcinoma were excluded. Biochemical response was based on the Paris-II criteria. LSM response was defined as stable or any reduction in LSM. The primary outcome was the occurrence of the first HD. Secondary outcomes were liver transplantation and liver-related death. The influence of LSM on HD was estimated using Cox regression analysis. RESULTS: A total of 1,793 patients with PBC were analyzed. Over a median follow-up of 22 (IQR 12-39) months, 3.3% developed HD. Up to 55% of patients with PBC exhibited discordance between LSM and biochemical response. Among patients with LSM response, achieving Paris-II criteria was associated with a lower risk of HD (hazard ratio [HR] 0.25, 95% CI 0.06-0.97, p 10 kPa strongly predicted HD (HR 14.5, 95% CI 6.9-30.6, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Liver Unit, University of Alberta, Edmonton, Canada; Department of Gastroenterology & Hepatology, Changi General Hospital, Singapore.
- Pierre Louis Institute of Epidemiology and Public Health, Sorbonne University, Inserm, Paris, France; Public Health Unit, Saint-Antoine Hospital, Assistance Publique - Hôpitaux de Paris, France.
- Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis, European Reference Network on Hepatological Diseases (ERN Rare-Liver), Saint-Antoine Hospital, Assistance Publique - Hôpitaux de Paris; Inserm…
- Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Canada; Department of Epidemiology & Biostatistics, Erasmus MC, Rotterdam, the Netherlands.
- Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Canada.
- Division of Preventive Medicine, University of Alberta, Edmonton, Alberta, Canada.
Zitieren
APA
Wong, Y. J., Lam, L., Soret, P. A., Lemoinne, S., Hansen, B., Hirschfield, G., Gulamhusein, A., Lytvyak, E., Pares, A., Olivas, I., Londono, M. C., Rogriguez-Tajes, S., Eaton, J. E., Osman, K. T., Schramm, C., Sebode, M., Lohse, A. W., Dalekos, G., Gatselis, N., …, & Chazouillères, O. (2026). Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis. Journal of Hepatology, 84(2), 275-283. https://doi.org/10.1016/j.jhep.2025.09.024
Vancouver
Wong YJ, Lam L, Soret PA, Lemoinne S, Hansen B, Hirschfield G, et al. Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis. Journal of Hepatology. 2026;84(2):275-283. doi:10.1016/j.jhep.2025.09.024
BibTeX
@article{Wong2026,
author = {Wong, Yu Jun and Lam, Laurent and Soret, Pierre-Antoine and Lemoinne, Sara and Hansen, Bettina and Hirschfield, Gideon and Gulamhusein, Aliya and Lytvyak, Ellina and Pares, Albert and Olivas, Ignasi and Londono, Maria-Carlota and Rogriguez-Tajes, Sergio and Eaton, John E and Osman, Karim T and Schramm, Christoph and Sebode, Marcial and Lohse, Ansgar W and Dalekos, George and Gatselis, Nikolaos and Nevens, Frederik and Cazzagon, Nora and Zago, Alessandra and Russo, Francesco Paolo and Floreani, Annarosa and Abbas, Nadir and Trivedi, Palak and Thorburn, Douglas and Saffioti, Francesca and Barkai, Laszlo and Roccarina, Davide and Calvaruso, Vicenza and Fichera, Anna and Delamarre, Adèle and Sobenko, Natalia and Villamil, Alejandra Maria and Medina-Morales, Esli and Bonder, Alan and Patwardhan, Vilas and Rigamonti, Cristina and Carbone, Marco and Invernizzi, Pietro and Cristoferi, Laura and van der Meer, Adriaan and de Veer, Rozanne and Zigmond, Ehud and Yehezkel, Eyal and Kremer, Andreas E and Deibel, Ansgar and Bruns, Tony and Große, Karsten and Wetten, Aaron and Dyson, Jessica Katharine and Jones, David and Levy, Cynthia and Tanaka, Atsushi and Dumortier, Jérôme and Pageaux, Georges-Philippe and de Lédinghen, Victor and Carrat, Fabrice and Chazouillères, Olivier},
title = {Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis},
journal = {Journal of Hepatology},
year = {2026},
volume = {84},
number = {2},
pages = {275--283},
doi = {10.1016/j.jhep.2025.09.024}
}
EUVIMED